Tag: Gary Petersen
Goals and challenges of developing a patient focused myeloma center of excellence
The multiple myeloma treatment field has undergone several changes over the past 10-20 years. The average overall survival has changed from 1-3 years to 10-20 years. Yet, there is no established curative therapy for multiple myeloma. However, advanced monitoring with…
Novel Cancer Immunotherapies with SELLAS Life Sciences
The second episode of CureTalks with Gary discusses new immunotherapies with Sellas Life Sciences. Talking to Gary Petersen is Dr Angelos M. Stergiou CEO and President of Sellas Life Sciences and Senior Advisor for Sellas, Dr. Nicholas J Sarlis. Sellas…